Initial Statement of Beneficial Ownership (Form 3)

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * Ratz Andrew 2. Date of Event Requiring Statement (Month/Day/Year) 03/15/2026 3. Issuer Name and Ticker or Trading Symbol NEUROCRINE BIOSCIENCES INC [NBIX] (Last) (First) (Middle) 6027 EDGEWOOD BEND CT. 4. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) Chief Technical Operations Off 5. If Amendment, Date Original Filed (Month/Day/Year) (Street) SAN DIEGO, CA 92130 6. Individual or Joint/Group Filing (Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5) Common Stock 1,018 D

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	(1)	Common Stock	3,997	(2)	D
Restricted Stock Unit	(3)	(3)	Common Stock	5,640	(2)	D
Incentive Stock Option	(4)	02/03/2035	Common Stock	2,664	$150.1	D
Non-Qualified Stock Option	(4)	02/03/2035	Common Stock	17,724	$150.1	D
Incentive Stock Option	(5)	02/13/2036	Common Stock	805	$124.12	D
Non-Qualified Stock Option	(5)	02/13/2036	Common Stock	31,348	$124.12	D

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Ratz Andrew 6027 EDGEWOOD BEND CT. SAN DIEGO, CA 92130			Chief Technical Operations Off

Signatures

/s/ Darin Lippoldt, Attorney-in-Fact		03/17/2026
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Represents Restricted Stock Units (RSUs) remaining outstanding as of March 15, 2026. The RSU vested and settled as to 1/4 of the total units on February 3, 2026. The remaining RSUs vest annually at 1/4 of the total units subject to the award vesting on each of February 3, 2027, February 3, 2028, and February 3, 2029.
(2)	Each RSU represents a contingent right to receive one share of the Issuer's common stock.
(3)	The RSUs will vest annually at 1/4 of the units vesting on each of February 13, 2027, February 13, 2028, February 13, 2029, and February 13, 2030.
(4)	Represents option of which 1/4th of the shares underlying the option became vested and exercisable on February 3, 2026 and an additional 1/48th of the shares underlying the option becomes vested and exercisable each month thereafter.
(5)	Represents option of which 1/48th of the shares underlying the option became vested and exercisable on March 13, 2026 and an additional 1/48th of the shares underlying the option becomes vested and exercisable each month thereafter.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.